Resolved

FENTANYL CITRATE INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of FENTANYL CITRATE INJECTION, USP in Canada?

Not currently. The most recent shortage report for FENTANYL CITRATE INJECTION, USP 50MCG is marked resolved (last updated July 8, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength50MCG

Last updated2026-07-08

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02501554

Strength

50MCG

Dosage Form

SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR EPIDURAL

Active Ingredient

FENTANYL

Tier

Unrated

Last Updated

2026-07-08

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

FENTANYL CITRATE INJECTION, USP has 2 shortage/discontinuation reports on file — this is one of them.

2026-08-11

Resolved

Other (Please describe in comments)

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482